21st week of 2013 patent applcation highlights part 44 |
Patent application number | Title | Published |
20130129584 | MICRO-CHANNEL REACTOR FOR PRODUCING SYNTHETIC NATURAL GAS - The present invention relates to a micro-channel reactor for producing synthetic natural gas, and more particularly, to a micro-channel reactor for producing synthetic natural gas containing methane gas from synthetic gas, including a porous nickel plate catalyst part. | 2013-05-23 |
20130129585 | METHOD FOR RECYCLING LEAD FROM WASTE GLASS CONTAINING LEAD - Disclosed is a method for recycling lead from waste glass containing lead, which comprises the following steps: mechanical crushing waste glass containing lead, ball milling and screening to obtain glass powder containing lead; alkaline roasting the glass powder containing lead to obtain a roasted material; mixing polycarboxylic acid complexant and nitric acid to produce leaching agent, and then placing the roasted material into the leaching agent to obtain leachate; regulating pH value of the leachate to solidify metal ion to obtain precipitate, separating and removing impurities, rinsing and drying to obtain chemical product containing lead. The method avoids environment pollution caused by waste glass containing lead. | 2013-05-23 |
20130129586 | METHOD FOR ECONOMICAL EXTRACTION OF LITHIUM FROM SOLUTION INCLUDING LITHIUM - The present invention relates to a method of extracting lithium from a lithium bearing solution. More specifically, the present invention provides a method of economical extraction of lithium from a lithium bearing solution by adding a phosphorous supplying material to the solution to precipitate lithium phosphate from the dissolved lithium. | 2013-05-23 |
20130129587 | Process Equipment Contaminant Removal - A method and system remove contaminants from a vapor. In one embodiment, the system includes a contaminant removal system having a vacuum box. A contaminated vapor from process equipment is introduced to the vacuum box. The contaminated vapor includes steam and hydrocarbons. The vacuum box includes a water removal device. The water removal device removes water from the contaminated vapor to provide water and a reduced water vapor. The water and the reduced water vapor are removed from the vacuum box. | 2013-05-23 |
20130129588 | Multi-Purpose Absorber - Systems and methods directed to cleaning a flue gas are described, in which a column housing can be configured to receive a feed stream, and includes an absorber configured to produce a clean stream that is substantially depleted of at least one of SO | 2013-05-23 |
20130129589 | Process for the Removal of Hydrogen Sulfide from a Gas Stream - The application relates to a process for the removal of hydrogen sulfide from a gas stream by catalytic direct oxidation without employing the combustion step of a Claus process. The process is particularly suitable for desulfurization of gas streams that contain hydrogen and allows sulfur recovery efficiency of better than 99%. | 2013-05-23 |
20130129590 | EXHAUST GAS PURIFYING CATALYST - To overcome the problem of a conventional catalyst and to provide an exhaust gas purifying catalyst that meets the requirement concerning Hg oxidation activity and SO | 2013-05-23 |
20130129591 | METHOD AND APPARATUS FOR SOx AND CO2 REMOVAL FROM FLUE GAS - The present invention relates to a method for combined SO | 2013-05-23 |
20130129592 | YTTRIUM HYDROXYCARBONATE MODIFIED WITH HETEROGENEOUS METAL, METHOD OF PREPARING THE SAME, AND ADSORBENT AND FILTER DEVICE INCLUDING THE SAME - Example embodiments relate to a yttrium hydroxycarbonate modified with a heterogeneous metal, a method of preparing the same, an adsorbent for a heavy metal including the same, and a filter device including the same. The modified yttrium hydroxycarbonate may have a pore size distribution with a pore diameter peak of less than or equal to 10 nm. | 2013-05-23 |
20130129593 | Metal Complex Compositions and Methods for Making Metal-Containing Films - The present invention provides compositions of matter useful as deposition agents for making structures, including thin film structures and hard coatings, on substrates and features of substrates. In an embodiment, for example, the present invention provides metal complexes having one or more diboranamide or diboranaphosphide ligands that are useful as chemical vapor deposition (CVD) and/or atomic layer deposition (ALD) precusors for making thin film structures and coatings. Metal complex CVD precursors are provided that possess volitilities sufficiently high so as to provide dense, smooth and homogenous thin films and coatings. | 2013-05-23 |
20130129594 | PROCESS FOR MANUFACTURING A NANOMETRIC CAGE AND ASSOCIATED CAGE - A method for manufacturing a nanoscale cage of a material suitable for forming a molecular layer, including a step of shaping and packaging an object in the general shape of a revolving cylinder, the shaping and packaging step being adapted according to the position of the value of the diameter of the revolving cylinder relative to a threshold below which a folding of the ends of the cylinder is promoted. | 2013-05-23 |
20130129595 | Manufacture of LiPO2F2 from POF3 or PF5 | 2013-05-23 |
20130129596 | DEVICE FOR PREPARING INORGANIC COMPOUND AND METHOD FOR PREPARING INORGANIC COMPOUND USING THE SAME - Disclosed is a device for continuously preparing an inorganic slurry by a hydrothermal method including a precursor liquid or slurry stream containing a precursor for preparing an inorganic substance, a supercritical liquid stream containing high-temperature and high-pressure water, and a reactor into which the precursor liquid or slurry stream and the supercritical liquid stream are injected, and from which an inorganic slurry obtained as a reaction product of hydrothermal reaction between the precursor liquid or slurry stream and the supercritical liquid stream is continuously discharged, wherein an injection direction of the precursor liquid or slurry stream forms an angle of 0 to 60 degrees with respect to a discharge direction of an inorganic slurry stream (inorganic substance stream) containing the inorganic slurry in the reactor. | 2013-05-23 |
20130129597 | SURFACE-TREATED METAL OXIDE PARTICLES - The invention provides metal oxide particles surface-treated with at least one alkoxysilane compound, methods of making such, and toners comprising same. | 2013-05-23 |
20130129598 | SILICON CARBIDE AND METHOD FOR MANUFACTURING THE SAME - Provided is a method for manufacturing silicon carbide. The method includes mixing a dry silicon source, a solid carbon source, and a binder with each other and heating the mixed source to form silicon carbide. | 2013-05-23 |
20130129599 | SILICON CARBIDE AND METHOD FOR MANUFACTURING THE SAME - Disclosed are a silicon carbide and a method for manufacturing the same. The method for manufacturing silicon carbide includes mixing a silicon source with a carbon source, and heating a mixture of the silicon and carbon sources to form the silicon carbide. At least one of the silicon source and the carbon source has an average grain size of about 10 nm to about 100 nm. | 2013-05-23 |
20130129600 | METHOD FOR PRODUCING METAL NITRIDE - There is provided a method for producing a high-purity metal nitride by simple processes with good yield. | 2013-05-23 |
20130129601 | LIME CAUSTICIZATION PRODUCT BRIGHTNESS IMPROVEMENT VIA PRE-SLAKING - A method for obtaining particulate calcium carbonate exhibiting improved brightness and color and having uniformity of size such that when the particles are formed in the causticization process in a kraft pulp mill, the time required to separate the particles from liquors in which they are suspended is minimized and the amount of liquor recovered is maximized, with minimal dilution by water used for washing. The method includes the steps of a) slaking calcium oxide in water or an alkaline liquor containing as dissolved species predominantly sodium hydroxide; b) mixing the slaked lime with green liquor from a kraft pulping process to complete a causticization reaction that produces white liquor and lime mud; c) separating the lime mud from the white liquor; and d) milling a portion of the lime mud for use as a white mineral pigment in applications where such pigments are typically used. | 2013-05-23 |
20130129602 | RECYCLING OF SOLID WASTE IN IONIC LIQUID MEDIA - A method for recycling rubber tires includes mixing the rubber tires and a hydrophobic ionic liquid in a vessel. The hydrophobic ionic liquid is heated to an elevated vapor temperature to produce dissolved components from the rubber tires. A precipitate is produced from at least some of the dissolved components. | 2013-05-23 |
20130129603 | Tellurium (Te) Precursors for Making Phase Change Memory Materials - Tellurium (Te)-containing precursors, Te containing chalcogenide phase change materials are disclosed in the specification. A method of making Te containing chalcogenide phase change materials using ALD, CVD or cyclic CVD process is also disclosed in the specification in which at least one of the disclosed tellurium (Te)-containing precursors is introduced to the process. | 2013-05-23 |
20130129604 | METHOD FOR PRODUCING AMMONIUM DICHROMATE - Process for preparing ammonium dichromate, comprising the steps of
| 2013-05-23 |
20130129605 | Lime Slaking Process - A lime slaking process is provided, whereby lime is delivered from a silo into a slaking vessel, and water is likewise delivered from one or more sources, into the slaking vessel, such that unreacted lime will go through a hydration process in an exothermic reaction, and wherein the temperature of the lime being slaked in the slaking vessel is monitored and controlled via a computer that responds to the monitored temperature of lime being slaked, to add additional water and/or lime, as desired. The delivery of lime from a lime silo to the slaking vessel is via a volumetric feeding apparatus. Following the slaking process, the reacted lime and water, in the form of a slurry may be delivered to an aging tank, and subsequently to a gravity operated grit classifier. Water from the slurry may be drawn off for use at one or more dosing stations. | 2013-05-23 |
20130129606 | METHOD FOR TEMPERATURE CONTROL IN A SLAKER - Method for batch wise slaking of burnt lime in a slaker, in which a lime slurry is produced with a great degree of fineness and long sedimentation time, comprising the following steps: the regulation of the slaking temperature is carried out in either of two steps—at incoming water temperatures between 0-10° C. a predetermined amount of the finished slurry is emptied out—at incoming water temperatures between 10-20° C. a predetermined amount of flushing water or diluting water is added. | 2013-05-23 |
20130129607 | SYNTHESIS OF STANNANE AND DEUTEROSTANNANE - The present invention relates to a process for the preparation of stannane and deuterostannane by reacting a stannic halide with lithium aluminum hydride or aluminum deuteride respectively in a polydentate solvent. | 2013-05-23 |
20130129608 | POROUS COORDINATION POLYMER, PROCESS FOR PRODUCING SAME, GAS STORAGE METHOD, AND GAS SEPARATION METHOD - The porous coordination polymer of the invention contains metal complexes formed by coordination bonding between a trivalent metal ion and an aromatic tricarboxylic acid represented by formula (1). The porous coordination polymer also has a pore structure formed by integration of a plurality of the metal complexes. | 2013-05-23 |
20130129609 | CATALYTIC SYSTEM FOR CATALYTIC PARTIAL OXIDATION PROCESSES WITH A SHORT CONTACT TIME - The present invention relates to a catalytic system comprising at least two catalytic zones of which at least one zone exclusively contains one or more noble metals selected from the group consisting of Rhodium, Ruthenium, Iridium, Palladium and Platinum and at least another zone contains Nickel, said catalytic system characterized in that at least one zone exclusively containing noble metals selected from the group consisting of Rhodium, Ruthenium, Iridium, Palladium and Platinum is always distinct but in contact with at least one zone containing Nickel. One or more metals selected from the group consisting of Rhodium, Ruthenium, Iridium, Palladium and Platinum are possibly added to the catalytic zone or zones comprising Nickel. | 2013-05-23 |
20130129610 | HYDROGEN/SYNGAS GENERATOR - The present invention relates to a compact, concentric auto thermal hydrogen/syngas generator for production of hydrogen/syngas without any external heating. Further, the auto thermal hydrogen/syngas generator of the present invention involves combination of reactions such as partial oxidation, steam reforming, dry reforming, auto thermal reforming, dry autothermal reforming, water gas shift, preferential oxidation or methanation that takes place without external heating, for converting air, steam and fuel into a reformate mainly containing CO, CO | 2013-05-23 |
20130129611 | Organotemplate-free Synthetic Process for the Production of a Zeolitic Material of the CHA-Type Structure - The present invention relates to an organotemplate-free synthetic process for the production of a zeolitic material having a CHA-type framework structure comprising YO | 2013-05-23 |
20130129612 | Process for Ion Exchange on Zeolites - Aspects of the present invention relate to an improved process for exchanging alkali metal or alkaline earth metal ions in zeolites for ammonium ions. For this exchange, aqueous solutions of ammonium salts, for example ammonium sulfate, ammonium nitrate or ammonium chloride, are currently being used. The resulting “ammonium zeolites” are calcined to convert them, with release of ammonia, to the H form of the zeolites suitable as a catalyst. Certain methods provided herein use ammonium carbonate instead of the ammonium compounds mentioned. As excess ammonium carbonate, in contrast to the nitrates, sulfates or chlorides, can be recycled in the form of carbon dioxide and ammonia, the amount of salt which has to be discharged is lowered significantly. | 2013-05-23 |
20130129613 | Process for Ion Exchange on Zeolites - Aspects of the present invention relate to an improved process for exchanging sodium ions in zeolites comprising sodium ions and rare earth metal ions for ammonium ions. For this exchange, aqueous solutions of ammonium salts, for example ammonium sulfate, ammonium nitrate or ammonium chloride, are currently being used. The resulting “ammonium zeolites” are calcined to convert them, with release of ammonia, to the H form of the zeolites suitable as a catalyst. The use of ammonium carbonate also minimizes the amount of rare earth metal ions which are leached out of the zeolites comprising rare earth metal ions. | 2013-05-23 |
20130129614 | Microorganisms for imaging and/or treatment of tumors - Modified viruses encoding transporter proteins and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses also can be used in diagnostic methods, such detection and imaging of tumors. The viruses also can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including as anti-tumor agents. | 2013-05-23 |
20130129615 | METHODS, COMPOSITIONS AND KITS FOR PROVIDING A THERAPEUTIC TREATMENT - The present invention encompasses a therapeutic method which employs treatment of a disease such as cancer with triiodothyronine (T3) together with an anti-thyroid treatment such as treatment with an anti-thyroid agent, treatment with radioiodine and surgical removal of all or part of the thyroid gland. A pharmaceutical composition comprising T3 and an anti-thyroid agent and a kit comprising the same are also encompassed by the invention. | 2013-05-23 |
20130129616 | GEL COMPOSITION FOR FILLING A BREAST MILK DUCT PRIOR TO SURGICAL EXCISION OF THE DUCT OR OTHER BREAST TISSUE - The invention is a gel composition for delivery to a breast milk duct prior to surgical excision of breast tissue including cancerous lesions. The invention also provides methods of mapping all or nearly all of a breast milk duct prior to surgical excision of breast tissue, and method of identifying part or all of a breast duct or ducts as a surgical aide to a breast surgeon. Kits to support these methods and including these compositions are also provided. | 2013-05-23 |
20130129617 | Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody - An anti-IL-12 antibody that binds to a portion of the IL-12 protein corresponding to at least one amino acid residue selected from the group consisting of residues 15, 17-21, 23, 40-43, 45-47, 54-56 and 58-62 of the amino acid sequence of the p40 subunit of IL-12, including isolated nucleic acids that encode at least one anti-IL-12 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in treating IL-12-related disorders, such as psoriatic arthritis. | 2013-05-23 |
20130129618 | EGCG STABILIZED GOLD NANOPARTICLES AND METHOD FOR MAKING SAME - The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from epigallocatechin Gallate (EGCg), which is a polyphenols- or flavanoids-rich plant material that can be obtained from green tea. The EGCg is an an antioxidant reducing agent derived from green tea. The gold nanoparticles of the invention can be radioactive or non radioactive and are formed via a simple room temperature fabrication method. In preferred embodiment method of making, an aqueous solution containing gold salts is provided. The aqueous solution is mixed with EGCg in a buffer, such as deionized water. The gold salts react to form biocompatible gold nanoparticles that are stabilized with a coating of EGCg. The thermodynamically feasible redox couple of AuCl4-EGCg leading to the reduction of AuCl4- by EGCg to form gold nanoparticles. In another embodiment, pre-cooled gold salt and EGCg solutions form multi-layered EGCg coated particles. | 2013-05-23 |
20130129619 | Molecular Imaging of Cancer Cells In Vivo - Cellular targets on cancer cells have been identified that can be used with targeted molecular imaging to detect the cancer cells in vivo. Non-invasive methods for detecting cancer cells, such as metastasized cancer cells, are therefore provided. Also provided are compositions and kits for use in the disclosed methods. | 2013-05-23 |
20130129620 | Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging - Chelators of the formulae (I), (II) and (III) | 2013-05-23 |
20130129621 | Integrin Receptor Antagonists and Their Methods of Use - Compounds comprising R-G-Cysteic Acid (i.e., R-G-NH—CH(CH | 2013-05-23 |
20130129622 | CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF - The present invention, among others, relates to a compound having a structure according to formula (I) or a pharmaceutically acceptable salt thereof, wherein Xaa | 2013-05-23 |
20130129623 | RADIOPHARMACEUTICAL COMPOSITIONS - The present invention relates to | 2013-05-23 |
20130129624 | STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES - This invention relates to a method of imaging amyloid deposits and to styrylpyridine compounds, and methods of making radiolabeled styrylpyridine compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits. | 2013-05-23 |
20130129625 | IN VIVO IMAGING AGENTS - The present invention relates to the field of medical imaging, and in particular to imaging of disease states associated with the upregulation of the chemokine receptor 5 (CCR5). Imaging agents, precursors and methods are provided which are useful in imaging such disease states. | 2013-05-23 |
20130129626 | IN VIVO IMAGING AGENTS - The present invention relates to the field of medical imaging, and in particular to imaging of disease states associated with the upregulation of the chemokine receptor 5 (CCR5). Imaging agents, precursors and methods are provided which are useful in imaging such disease states. | 2013-05-23 |
20130129627 | Delivery of Nanoparticles to Neurons - A peptide attached to a nanoparticles (such as quantum dots) selectively directs the nanoparticles to neurons in a tissue or organism. | 2013-05-23 |
20130129628 | FUNCTIONALIZATION OF AND USE OF FUNCTIONALIZED SECOND HARMONIC GENERATING NANOPROBES - Functionalized second harmonic nanoprobes for imaging samples and a method of using such probes to monitor the dynamics different processeses using a variety of imaging techniques are provided. The functionalized second harmonic generating (SHG) nanoprobes are comprised of various kinds of nanocrystalline materials that do not possess an inversion symmetry and therefore are capable of generating second harmonic signals that can then be detected by conventional two-photon microscopy, and are provided with functional surface modifications that allow for targeted imaging of a variety of biological and non-biological processes and structures such as cell signaling, neuroimaging, protein conformation probing, DNA conformation probing, gene transcription, virus infection and replication in cells, protein dynamics, tumor imaging and cancer therapy evaluation and diagnosis as well as quantification in optical imaging. | 2013-05-23 |
20130129629 | MODULATION OF BCL11A FOR TREATMENT OF HEMOGLOBINOPATHIES - The invention relates to methods and uses of modulating fetal hemoglobin expression (HbF) in a hematopoietic progenitor cells via inhibitors of BCL11A expression or activity, such as RNAi and antibodies. | 2013-05-23 |
20130129630 | HYPERTHERMIA THERAPEUTIC AGENT DELIVERY SYSTEM - A medical delivery system that enables the delivery of therapeutic agents to malignant tissue utilizing delivery agents and heating of the delivery agents thereby causing the release of the therapeutic agents within the tumor is disclosed. The therapeutic agents may be chemotherapy agents, radiation therapy agents, and other appropriate materials. The magnetic nanoparticles encapsulated by the therapeutic agents in a biocompatible coating may be delivered to tumor sites utilizing attenuated strains of bacteria that seek and reside at tumor sites. An alternating magnetic field device with a prescribed frequency range may be used to induce heating of the magnetic nanoparticles in the patient thereby melting the coating and releasing the therapeutic agents within the tumor. | 2013-05-23 |
20130129631 | Fluorescent Probe for Imaging Lymph Nodes - Disclosed is a near-infrared fluorescent imaging agent comprising an indocyanine-based fluorescent dye and a liposome. The near-infrared fluorescent imaging agent of the present invention demonstrates high fluorescence intensity and a long anchoring time in sentinel lymph nodes, thereby making it useful for detecting sentinel lymph nodes in sentinel lymph node navigation surgery. Also disclosed is an indocyanine green derivative that is particularly suitable for use in the near-infrared fluorescent imaging agent of the present invention. | 2013-05-23 |
20130129632 | Quantum dot materials, methods for making them, and uses thereof - The disclosure provides quantum dot materials, compositions and methods useful in the treatment of various disorders. In particular, the disclosure provides cadmium-free and lead-free quantum dots. | 2013-05-23 |
20130129633 | MULTIMODAL NANOPARTICLES FOR NON-INVASIVE BIO-IMAGING - Multimodal nanoparticles are nanoparticles containing contrast agents for PAT and one or more of luminescence imaging, x-ray imaging, and/or MRI. The multimodal nanoparticles can have a dielectric core comprising an oxide with a metal coating on the core. The particles can be metal speckled. The multimodal nanoparticles can be used for therapeutic purposes such as ablation of tumors or by neutron capture in addition to use as contrast agents for imaging. | 2013-05-23 |
20130129634 | INTRINSICALLY MAGNETIC HYDROXYAPATITE - The present invention relates to hydroxyapatite doped with Fe | 2013-05-23 |
20130129635 | POLYMERIZED SHELL LIPID MICROBUBBLES AND USES THEREOF - The present invention relates to the fabrication and use of microbubbles. In some embodiments, the invention provides for the fabrication and use of polymerized shell lipid microbubbles (PSMs). The microbubbles of the invention can be used, for example, for diagnosis and treatment of a condition. | 2013-05-23 |
20130129636 | Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging - The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium(III)2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N′-amido-methyl]-1,4,7,10-tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal. | 2013-05-23 |
20130129637 | METHOD FOR PRODUCING RESERVOIR LAYER FOR HOOF TREATMENT AND RESERVOIR LAYER - The present invention provides a kit or article of manufacture comprising as separate components:
| 2013-05-23 |
20130129638 | Use of Glyceryl Trinitrate for Treating Traumatic Edema - Use of glyceryl trinitrate (GTN) for treating traumatic edemas. | 2013-05-23 |
20130129639 | Cassia Derivatives - This invention relates to a cationically and hydrophobically modified polygalactomannan having repeating units with a D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with a hydrophobic substituent and a cationic substituent. | 2013-05-23 |
20130129640 | Compressed Chewing Gum - A compressed chewing gum tablet including a chewing gum center, the gum center including a compression of gum base granules and chewing gum additives. The chewing gum additives include sweeteners and flavors. At least a first part of the gum base granules have granules of flavor incorporated gum base and at least a second part of the gum base granules have granules of conventional gum base. | 2013-05-23 |
20130129641 | METHODS AND COMPOSITIONS TO IMPROVE MECHANICAL RESISTANCE OF TEETH - Provided are compositions and methods for preventing dental caries, as well as aqueous compositions and methods for improving the mechanical strength of teeth. | 2013-05-23 |
20130129642 | ORAL CARE COMPOSITIONS - The invention provides an oral care composition suitable for delivering a temporary whitening effect to the surface of teeth, the composition comprising: a continuous phase comprising water or polyhydric alcohol or a mixture thereof; a tooth surface whitening agent which is dispersed in the continuous phase, and a deposition aid for the tooth surface whitening agent; characterised in that the tooth surface whitening agent is a lake dye formed by fixing a dye onto a particulate inorganic substrate, in which the dye used to form the lake dye is a triarylmethane dye having a blue to green-blue colour with a hue angle in the CIELAB system ranging from 180 to 270 degrees, and in which the amount of lake dye is at least 0.015% by total weight lake dye based on the total weight of the composition. | 2013-05-23 |
20130129643 | ORAL CARE COMPOSITIONS - An oral care composition for treating or preventing calculus comprising an anticalculus agent and an antibacterial agent comprising a biphenol compound obtainable from | 2013-05-23 |
20130129644 | SUNSCREEN COMPOSITION WITH POLYHYDROXY QUATERNARY AMMONIUM SALTS - A cosmetic composition is provided including a water-insoluble UV-A organic sunscreen agent having a | 2013-05-23 |
20130129645 | Personal Care Compositions with Silicones and Polyhydroxy Quaternary Ammonium Salts - A personal care composition is provided with a silicone compound and being aesthetically modified for improved skinfeel with a polyhydroxy quaternary ammonium salt of structure (I): | 2013-05-23 |
20130129646 | MENTHYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES - The present invention relates to the cosmetic, dermatological or pharmaceutical (therapeutic) use of compounds of formula (I) or a cosmetically acceptable salt of a compound of formula (I) or a mixture containing two or more of these compounds or the salts thereof | 2013-05-23 |
20130129647 | Compositions Having Hase Rheology Modifiers - A monomer compound that contains at least one polymerizable functional group per molecule, and at least one bicycloheptyl-, bicycloheptenyl-, or branched (C | 2013-05-23 |
20130129648 | SILICONE BASED COSMETIC COMPOSITIONS AND USES THEREOF - The present disclosure relates to silicone based cosmetic compositions comprising at least at least one silicone amine, at least one anionic silicone and a cosmetically acceptable carrier such as water and other components. The compositions are useful for treating keratinous substrates such as hair, for example, for styling, conditioning and/or improving the manageability of hair. The present disclosure also relates to silicone based hair coloring compositions comprising at least one silicone amine, at least one anionic silicone, at least one colorant, a cosmetically acceptable carrier; and optionally, at least one oxidizing agent. The compositions are useful for coloring hair. | 2013-05-23 |
20130129649 | SUNSCREEN COMPOSITIONS HAVING SYNERGISTIC COMBINATION FO UV FILTERS - The disclosure relates to sunscreen compositions having a synergistic combination of ultraviolet light (UV) filtering agents that provide a high sun protection factor (SPF). Compositions according to the disclosure have high SPF values without requiring high overall amounts of UV filtering agents. Furthermore, the disclosure relates to methods of using the described compositions for protecting keratinous substances such as skin and hair from UV radiation. | 2013-05-23 |
20130129650 | SUNSCREEN COMPOSITIONS HAVING SYNERGISTIC COMBINATION OF UV FILTERS - The disclosure relates to sunscreen compositions having a synergistic combination of ultraviolet light (UV) filtering agents that provide a high sun protection factor (SPF). Compositions according to the disclosure have high SPF values without requiring high overall amounts of UV filtering agents, and without requiring the use of oxybenzone. Furthermore, the disclosure relates to methods of using the described compositions for protecting keratinous substances such as skin and hair from UV radiation. | 2013-05-23 |
20130129651 | AGENT FOR ENHANCING THE EFFECT OF SKIN-WHITENING INGREDIENTS AND USES THEREOF - The present invention has objects to provide an agent for enhancing the effect of skin-whitening ingredients which enhances the skin-whitening action of skin-whitening ingredients and has an improved safeness, and to provide a skin-whitening agent, which contains the above agent and a skin-whitening ingredient(s) and has an improved and enhanced skin-whitening action. The present invention solves the above objects by providing an agent for enhancing the effect of skin-whitening ingredients, which contains one or more members selected from the group consisting of guanine and derivatives thereof as an effective ingredient(s); and a skin-whitening agent which contains the above agent along with a skin-whitening ingredient(s) particularly, members derivatives thereof and/or equol including derivatives thereof. | 2013-05-23 |
20130129652 | COLORED AQUEOUS COSMETIC COMPOSITIONS - The present invention relates to a cosmetic care and/or makeup composition comprising at least 65% by weight relative to its total weight of an aqueous phase, at least 2% by weight relative to its total weight of pigments in the form of pigmentary particles that are dispersed and/or dispersible in aqueous medium, at least one water-soluble or water-dispersible gelling agent in a content ranging from 0.05% to 40% by weight relative to the total weight of the composition, and at least one polyol containing from 3 to 12 carbon atoms, said composition having a viscosity at least equal to 600 Pa·s at a shear of 0.010 s—and less than 0.8 Pa·s at a shear of 1000 s—, and said pigmentary particles being first formed from an intimate mixture of said pigments and from at least one polyol. | 2013-05-23 |
20130129653 | COSMETIC USE OF A LYSATE OF BIFIDOBACTERIUM SPECIES FOR TREATING BODY ODOR - The present invention is directed toward protecting the cosmetic use of at least an effective amount of a lysate of at least one microorganism of the genus | 2013-05-23 |
20130129654 | ORGANOGEL STRUCTURED WITH 12-HSA AND A SELECTED COPOLYMER - Disclosed are organogels comprising selected amounts of 12-hydroxystearic acid gelator, cosmetically acceptable oil, a copolymer that carries at least 70% by weight of the copolymer of pendant alkyl groups having chain length of C | 2013-05-23 |
20130129655 | Organic Compounds - Compounds of formula (I) | 2013-05-23 |
20130129656 | "GREEN" DIESTER AMINES AND PERSONAL CARE PRODUCTS - Diester tertiary amines and quats and their methods of synthesis are disclosed. Also disclosed are personal care compositions comprising the disclosed compounds. | 2013-05-23 |
20130129657 | SPRAYABLE COMPOSITION COMPRISING HIGH MOLECULAR WEIGHT CHARGED POLYMER - Disclosed herein are sprayable compositions comprising: a complex of (A) at least one charged (or pseudo-charged) polymer having a molecular weight of about 125,000 amu or more; and (B) a least one oppositely charged, rheology modifying, crosslinked polymer having at least one carboxylic functional group. The composition may provide a spray with a median particle size of less than about 175 μm. Also disclosed are methods for preparing the compositions as well as creating the spray. The invention enables the spray of the high molecular weight charged (or pseudo-charged) polymer in any number of uses including personal care and performance chemicals application. | 2013-05-23 |
20130129658 | Rheology Modifying and Setting Polymer, Composition thereof and Method for Making It - The invention relates to a polymer suited for modifying the styling performance and the rheology of a cosmetic preparation, a composition thereof, a method of making it as well as the use of said polymer and the composition respectively. The copolymer comprises at least one non-ionic ethylenically unsaturated C1-C4 (meth)acrylate as monomer A; an ethylenically unsaturated monomer B having as hydrogen bond donor an amide group, said ethylenically unsaturated monomer B being an ethylenically unsaturated monomer having a cyclic amide moiety, as monomer B1 and/or, an ethylenically unsaturated monomer having an acyclic amide group, as monomer B2; at least one ethylenically unsaturated carboxylic acid as monomer C; a macromonomer D; optionally at least one cross-linker E; and optionally at least one further monomer F. | 2013-05-23 |
20130129659 | COMPOSITE ENTEROSORBENT - A composite enterosorbent has a substrate in the form of a sorbent based on hydrogel of polymethylsiloxane. For the purpose of complex normalization of the intestinal microflora it further comprises a polysaccharide selected from the group including lactulose, inulin, fructooligosaccharides, alginic acid in the form of its pharmaceutically acceptable salts, acacia, pectin, chitosan, lignin. Respectively, the preparation comprises 0.1 to 10 parts by weight of polysaccharides per 1 part by weight of hydrogel of polymethylsiloxane. | 2013-05-23 |
20130129660 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GASTROINTESTINAL DISORDERS AND GERD-RELATED RESPIRATORY DISORDERS - Disclosed herein are novel compositions and methods for treating or preventing GI tract disorders and/or GERD-related respiratory disorders as well as protecting stratified squamous epithelium against injury by a noxious substance. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising at least one bile acid sequestrant, alone or in combination with at least one proton pump inhibitor, and optionally one or more agent chosen from antacids, histamine H | 2013-05-23 |
20130129661 | MATERIAL FOR SKIN AND METHOD FOR PRODUCING MATERIAL FOR SKIN - A material for skin is provided including a silicone component-containing polymer obtained by polymerizing a silicone monomer having a carbon-carbon double bond, and a component selected from an antibacterial agent and an alcohol. Provided are a material for skin, which is transparent and has a moderate moisture content, and also has high oxygen permeability, and a method for producing the same. | 2013-05-23 |
20130129662 | Compositions and Methods for the Treatment of Heart Failure - The invention provides a therapeutic composition comprising an aqueous buffer, and a therapeutic agent that proves the functioning of a diseased heart by decreasing left ventricular end-diastolic pressure and simultaneously increasing left ventricular ejection without affecting the blood pressure or heart rate. | 2013-05-23 |
20130129663 | REVERSE THERMAL GELS AND USES THEREFOR - Biodegradable triblock copolymer compositions are provided which are useful in tissue engineering and drug delivery. The copolymers are reverse thermal gels in that when heated from a lower temperature to a higher temperature, they gel. These gels are useful in drug delivery when complexed with an active agent. For example the compositions can be used for intraocular injection of active agents, such as anti-angiogenic agents for treatment of a maculopathy or retinitis. | 2013-05-23 |
20130129664 | Cancer Therapy Via Selective Uptake of Specialized Nanoparticles in Cancer Cells - Disclosed herein are polymer/fullerene nanoparticles that have selective uptake into cancer cells, and which, upon being taken into the cancer cells induce apoptosis. Induction of apoptosis can be controlled by activation of the nanoparticles. Activation can occur such as by photoactivation, or other means. | 2013-05-23 |
20130129665 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY - The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein. | 2013-05-23 |
20130129666 | BIOMATERIAL CONTAINING DEGRADATION STABILIZED POLYMER - The invention provides a polymer based material comprising a water binding agent present in an amount sufficient to chemically and/or physically absorb and/or adsorb water to prevent degradation of the polymer. The invention also provides a polymer based material comprising a plasticizer or organic solvent as well as a multi-component material or composite including materials encompassing a second polymer and/or an active agent. The invention further provides a pharmaceutical composition comprising the aforesaid polymer based material, which can be used for treatment of bone, cartilage and/or periodontal defects. | 2013-05-23 |
20130129667 | Attractant compounds for yellow jacket wasps - The use of individual chemical compounds as attractants in traps for yellow jacket wasps | 2013-05-23 |
20130129668 | Diagnosis and treatment of arthritis using epigenetics - Embodiments of the present invention include methods, compositions and kits for evaluating a diagnosis, prognosis, or response to treatment of a subject with a disorder such as rheumatoid arthritis or osteoarthritis. Some embodiments include identifying a therapeutic agent for treating a disorder such as rheumatoid arthritis or osteoarthritis. | 2013-05-23 |
20130129669 | Stable Formulations of Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor - Described herein are compositions and methods for treating, preventing and ameliorating diseases and conditions characterized by a lower than normal white blood cell count, such as leukopenia and neutropenia. The compositions and methods include recombinant human albumin-human granulocyte colony stimulating factor. Pharmaceutical formulations including the recombinant fusion protein, and methods of making such formulations are also described. | 2013-05-23 |
20130129670 | MACROPHAGE ACTIVATING FACTOR FOR USE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME (CFS) AND CFS-RELATED DISEASES AND DISORDERS - The present invention relates to Macrophage Activating Factors such as GcMAF and compositions thereof, for use in the treatment of a patient suffering from CFS/ME and/or XMRV infection. | 2013-05-23 |
20130129671 | Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus - Hepatitis C virus inhibitors having the general formula (I) | 2013-05-23 |
20130129672 | MUTANTS OF INTERLEUKIN- 1 RECEPTOR ANTAGONIST AND USES THEREOF - The invention provides an isolated polypeptide comprising a variant amino acid sequence of SEQ ID NO: 1, or a fusion or derivative of said polypeptide, or a fusion of a said derivative thereof, wherein the polypeptide, fusion or derivative retains a biological activity of wild type IL-IRa. In one embodiment, the isolated polypeptide, fusion or derivative is or comprises a polypeptide variant of amino acid sequence SEQ ID NO: 1 comprising or consisting of substitutions at one or more of the following amino acid mutations of SEQ ID NO: 1: Q29K, P38Y, P38R, L42W, D47N, E52R, H54R, E90Y, Q129L, Q129N, M136N, M136D and Q149K. Also provided are pharmaceutical compositions of the above polypeptide, fusion or derivative, as well as uses of the same for treating a disease or condition capable of being treated by an agent which inhibits the function of IL-1 receptors. | 2013-05-23 |
20130129673 | USE OF ENDOGENOUS ANTIOXIDANT PROTEINS IN THE TREATMENT OF STROKE - Oligodendrocytes (OLs), the predominant cell type found in cerebral white matter, are essential for structural integrity and proper neural signaling. Very little is known concerning stroke-induced OL dysfunction. Infusion of human umbilical cord blood (HUCB) cells protects striatal white matter tracts in vivo and directly protects mature primary OL cultures from oxygen glucose deprivation (OGD). Microarray studies of RNA prepared from OL cultures subjected to OGD and treated with HUCB cells showed an increase in the expression of 33 genes associated with OL proliferation, survival, and repair functions, such as myelination. Immunohistochemistry showed antioxidant protein expression was upregluated in the ipsilateral white matter tracts of rats infused with HUCB cells 48 hrs after middle cerebral artery occlusion (MCAO). These results show expression of genes induced by HUCB cell therapy that could confer oligoprotection from ischemia. | 2013-05-23 |
20130129674 | IL-12 FORMULATIONS FOR ENHANCING HEMATOPOIESIS - Provided are formulations for proteins to be injected into mammals. Specifically, formulations for recombinant IL-12 in mice and primates. | 2013-05-23 |
20130129675 | INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION - Methods of modulating the INF-induced STAT3 activation in a patient in need-thereof are provided for the treatment of disease. The methods comprise the step of administrating to a patient the combination of a therapeutically effective amount of interferon including INF-α and/or INF-β in combination with a STAT3 inhibitor. | 2013-05-23 |
20130129676 | COMBINATION OF ANTI-ENVELOPE ANTIBODIES AND ANTI-RECEPTOR ANTIBODIES FOR THE TREATMENT AND PREVENTION OF HCV INFECTION - The present invention provides combinations of antibodies for use in the treatment or the prevention of HCV infection. In particular, combinations are provided that comprise at least one anti-HCV envelope antibody and at least one anti-HCV receptor antibody, wherein the anti-HCV-envelope antibody and anti-HCV-receptor antibody act in a highly synergistic manner to inhibit HCV entry into susceptible cells. Also provided are pharmaceutical compositions and kits comprising such combinations and methods of using these compositions and kits for treating or preventing HCV infection. | 2013-05-23 |
20130129677 | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections - Methods and pharmaceutical compositions for treating viral infections, by administering certain thienopyridine derivative compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment of viral infections such as caused by flavivirus is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. | 2013-05-23 |
20130129678 | CO-ADMINISTRATION OF A PARVOVIRUS AND A CYTOKINE FOR THERAPY OF PANCREATIC CANCER - The application relates to a combination of a parvovirus and a cytokine, preferably IFNγ, for use in treating pancreatic cancer (PDAC), in particular a terminal stage of this disease. | 2013-05-23 |
20130129679 | INTERFERON BETA AS ANTIBACTERIAL AGENTS - The present invention describes method of treating bacterial infections, including MRSA. In various embodiments, the methods can use interferon beta, which is found to have antimicrobial activity. In certain embodiments, the interferon beta can be human interferon beta. In other embodiments, the interferon beta can be mouse interferon beta. In further embodiments, the interferon beta can be human interferon beta containing amino acid substitutions to make the human interferon beta more cationic in neutral pH. | 2013-05-23 |
20130129680 | METHOD FOR TREATING HEPATITIS C VIRUS INFECTION USING QUERCETIN-CONTAINING COMPOSITIONS - A method for treating hepatitis C virus infection with a composition containing quercetin, together with one or more of vitamin B | 2013-05-23 |
20130129681 | METHODS FOR DIAGNOSING SOLID TUMORS - An embodiment of the present invention is useful for identifying tumor cells in bladder cancer washes, pleural effusions, biliary tumor cells and circulating tumor cells in whole blood. Subsequent analysis may identify therapeutic treatments based on a single cell analysis of activatable elements in cell signaling pathways. This analysis can be useful for diagnosis, prognosis, therapy selection and monitoring of solid tumor diseases. | 2013-05-23 |
20130129682 | HAEMOPHILUS PARASUIS POLYPEPTIDES AND METHODS OF USE - The present invention provides isolated polypeptides having oligopeptide permease activity and an amino acid sequence that has at least 80% identity with a | 2013-05-23 |
20130129683 | Modified Rodent Parvovirus Capable of Propagating and Spreading Through Human Gliomas - Described are (a) parvovirus variants capable of propagating and spreading through human tumor cells which is obtainable by serially passaging a rodent parvovirus as starting strain in semi-permissive human tumor cells, and (b) parvovirus variants capable of propagating and spreading through human tumor cells characterized by particular amino acid deletions and/or substitutions, e.g. a deletion of several amino acids in the C-terminus of NS1/middle exon of NS2. A pharmaceutical composition containing such parvoviruses as well as their use for the treatment of cancer, preferably a glioblastoma, is also described. | 2013-05-23 |